marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2021-Q4
added 11-14-2022
MEDIROM Healthcare Technologies Balance Sheet 2011-2024 | MRM
Annual Balance Sheet MEDIROM Healthcare Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | 645 M | 8.48 M | 545 M | - | - | - | - | - | - | - |
Long Term Debt |
- | 668 M | 151 M | 343 M | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 1.17 B | 1.89 B | 2.29 B | - | - | - | - | - | - | - |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 2.66 B | 4.16 B | 4.64 B | - | - | - | - | - | - | - |
Deferred Revenue |
- | 442 M | 483 M | 522 M | - | - | - | - | - | - | - |
Retained Earnings |
- | -2.1 B | -705 M | -723 M | - | - | - | - | - | - | - |
Total Assets |
- | 3.04 B | 4.76 B | 4.52 B | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | 380 M | 600 M | -118 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | - | - | - | - | - | - | - |
All numbers in JPY currency
Quarterly Balance Sheet MEDIROM Healthcare Technologies
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 747 M | - | - | - | 668 M | - | - | - | 151 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 5.96 B | - | - | - | 5.22 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | 104 M | - | - | - | 172 M | - | - | - | 202 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | -2.69 B | - | - | - | -1.7 B | - | - | - | -705 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | 5.75 B | - | - | - | 5.71 B | - | - | - | 4.76 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | 371 M | - | - | - | 1.44 B | - | - | - | 514 M | - | - | - | 212 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | -208 M | - | - | - | 491 M | - | - | - | 4.76 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | -208 M | - | - | - | 491 M | - | - | - | 600 M | - | - | - | -118 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in JPY currency